Clinical Trial Update: Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial using a molecularly targeted radionuclide therapy directed at integrin alphavbeta6 for metastatic non-small cell lung cancer is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Integrin alphavbeta6-targeted radionuclide therapy

Snippet

Sponsor: University of California, Davis | Conditions: Metastatic Nonsmall Cell Lung Cancer | Phase 1 | Status: RECRUITING